April 1, 2008

Johns Hopkins, Cleveland Clinic ban latex gloves from their ORs

By: OR Manager
PDF
Share

The prospect of a surgical glove conversion is enough to make many OR directors think about retirement. Latex gloves, with their comfort, fit, and flexibility, have been the mainstay in ORs for generations. Now some major hospitals, including Johns Hopkins Hospital in Baltimore—whose first chief of surgery, William Halsted, is credited with introducing rubber surgical gloves in the US in the 1890s—and the Cleveland Clinic’s network of 9 hospitals have switched entirely to synthetic surgical gloves.

Use of latex gloves became an issue in the late 1980s when latex allergy became an epidemic. The epidemic has been linked to shortcuts taken when glove production increased to meet the demand created by universal precautions.

Glove powder was identified as a major culprit in latex allergy about 15 years ago. Powder released into the air carries allergenic latex proteins that can be inhaled. A1996 study found a direct correlation between airborne latex allergens and use of powdered latex gloves in the OR. Powder has also been linked to other problems, such as granulomas and adhesions in surgical patients.

In response, companies began producing powder-free, lower-protein latex gloves. Many ORs switched to these improved latex gloves, providing synthetic gloves and other nonlatex supplies for latex-sensitized patients and clinicians.

Why banish latex gloves?

Why take the extra step of banning latex gloves?

Johns Hopkins made the decision for 2 major reasons, says Robert H. Brown, MD, MPH, chair of the Johns Hopkins Latex Task Force. First, though powder-free gloves are assumed to have lower protein content that should reduce latex sensitization, “we don’t know that, and I’m not sure we’ll ever have that data to support that claim, ” Dr Brown told OR Manager. He says it would not be ethical or practical to conduct a randomized trial to determine the risk of sensitization. Also, tests to quantify latex allergen levels aren’t perfect, and there is no known “cut-off” level below which latex proteins won’t sensitize an individual.

Second, it can be difficult to identify patients who are latex sensitive before surgery.

“For a large part of our patients, we don’t have that information even when we ask the question,” which is particularly critical for children, he says. One factor is the hospital’s population of spina bifida patients, who are one of the highest-risk groups for latex allergy. Though the policy is never to use latex gloves with these patients, the hospital did not want to run the risk that an accidental exposure might occur.

“We felt the only clear, safe thing to do was to go totally with nonlatex gloves and remove other latex products whenever there is an alternative. My feeling is that you need to make it easier for people to do their jobs.” Changing practice when you find a patient may have a latex allergy doesn’t make the job easier, he notes.

Johns Hopkins has been moving toward a latex-safe environment for about 10 years and completed the glove conversion about a year ago. One major factor—the OR’s senior executive team was all on board, including the chief of surgery, chief of anesthesia, nursing leaders, and other key administrators.

Cleveland Clinic converts

The rationale is similar for the Cleveland Clinic, which completed the conversion for all 9 hospitals in its network in January.

“Our expectation was to remove latex gloves all together,” says Shannon Phillips, MD, MPH, patient safety officer, who led the project. She and her team were charged with the conversion by top executives, including the CEO and chief of the medical staff. Though synthetic gloves are more costly, she says removing latex was a priority for the leadership.

It’s estimated that 80% of patients’ contact with latex in the hospital is from gloves, Foley catheters, and phlebotomy supplies, she points out. Before conversion, 80% to 90% of gloves used in the OR were latex.

“We wanted our patients and staff protected,” she says, noting that a latex allergy is not only a hazard for patients but also can drive OR staff and physicians from their professions.

The surgeons have been supportive. “They see this as the right thing to do,” she says. “They are attached to their teams, and they see this as a way to keep people healthy.”

Better quality and a wider choice of synthetic gloves also made a difference. Once surgeons and staff tried the nonlatex gloves, “we got many positive comments,” she says. “Overall, the product availability today really mirrors latex.”

Managing the conversion

Both Johns Hopkins and the Cleveland Clinic say the conversion was smoother than anticipated.

Having all of the leadership on board made a big difference at Johns Hopkins, notes Laurie Saletnik, RN, MSN, assistant director, surgical nursing. Consensus evolved over a number of years.

Two full glove trials were conducted, with physicians and staff invited to give written feedback. Three vendors participated, with the goal to select one. In the end, 2 vendors were chosen, because some surgeons preferred the second brand. Before the conversion, company reps were at the hospital for 4 weeks to assist OR personnel and answer questions. The final conversion was made all at once on a Friday night when all latex gloves were removed and the new synthetic gloves stocked.

Though Johns Hopkins says the synthetics cost 30% to 50% more than the latex gloves, “we considered this a safety issue from the start,” and that outweighed the extra cost, says Robert Scheu, RN, MBA, senior director of perioperative services.

Says Dr Phillips of the Cleveland Clinic: “With good planning, the conversion ended up being no big deal. We would encourage people that this is doable.” Her advice on a successful conversion:

  • The organization’s leadership must back the decision.
  • Find champions who will support the conversion, not only surgeons but also nurses and surgical technologists. “In each hospital, we had clinicians who were already using nonlatex gloves because they are allergic or had used them in training. We brought them to the table,” she says. The task force also invited employees and patients with latex allergy to tell their stories about the impact on their lives. “That makes it real,” she says.
  • Plan the conversion carefully. In the week or so before the conversion, the glove companies held a “glove fair” so clinicians could try on gloves and select a size. Then on the given date, all latex gloves were removed and synthetics stocked. Company reps were on hand during the conversion to assist and answer questions.

“It’s been fantastic to be able to say that latex is no longer a reason a health care professional will have to walk away from their passion,” Dr Phillips says.

Barrier quality

Glove failure was a concern with earlier versions of synthetic gloves. Dr Phillips says the gloves the Cleveland Clinic buys must meet at a minimum the ASTM D 3577 standard for surgical gloves, which covers freedom from holes, tensile strength, and powder and protein content.

The task force is monitoring glove failures to see if there are any common threads, such as long cases. Though there have been occasional breaks, as there were with latex gloves, she says they haven’t seen a disproportionate amount of failures with the synthetics. Also, the number of gloves used has not increased.

In a 2004 report, synthetic gloves were found to have a higher failure rate than latex gloves after actual use in surgery. The study is one of the only ones to test surgical gloves after clinical use. The research was conducted before newer synthetics were introduced. The researcher, Denise Korniewicz, RN, DNSc, FAAN, says she has been unable to to repeat the study because of lack of funding.

Glove standards

The AORN Latex Guideline recommends selecting latex products that are low allergen and powder free.

The US Food and Drug Administration has not set a limit for the amount of protein or powder in gloves. To aid users in identifying protein and powder content, the FDA allows companies to label surgical gloves as lower in protein and powder free if they meet the ASTM standard D 3577.

The FDA also requires medical products containing natural rubber latex to be labeled as such. But there is no requirement that products be labeled as “latex free.”

The FDA is tightening its standards for the number of leaks and visual defects like pinholes gloves can have. This is called the acceptable quality level (AQL), which the FDA uses in random testing. A new rule, to be implemented at the end of 2008, sets a more stringent AQL of 1.5 for surgical gloves and 2.5 for exam gloves.

Reducing the risk

Probably the most common strategy health care facilities are using to reduce the risk of latex allergy is to use powder-free, lower-protein gloves with nonlatex gloves for patients and employees who are latex allergic.

A new bulletin from the Occupational Safety and Health Administration (OSHA) notes that as one approach employers can take. The bulletin is advisory only and does not create any new requirements.

OSHA cites 4 studies showing that reducing the level of latex proteins in the environment decreases the likelihood of reactions, both from inhaling powder and having it on the skin.

OSHA also cites studies showing benefits when facilities switched to lower-protein, powder-free gloves, including fewer allergy symptoms and a decrease in positive skin-prick tests.

In a 2006 report by Filon and Radman, following up on 1,040 health care workers in Italy, symptoms significantly improved and in most cases disappeared after a change to powder-free gloves. A national study in Germany by Allmers et al published in 2002 found suspected cases of latex allergy declined after powder-free gloves with reduced protein were adopted.

There have also been large reviews published recently, including a meta-analysis by Bousquet and colleagues and LaMontagne and colleagues, that found the evidence on whether lower-protein, powder-free gloves reduced sensitization is moderate to low, and the subject hasn’t been sufficiently studied.

More research is under way, with results still to be reported.

Glove market

The lion’s share of the surgical glove market is still natural rubber latex, with synthetics making up about 22% in 2007, according to the market research firm Frost & Sullivan. Use of synthetics has been increasing at a faster rate than latex, by about 25% a year in 2005 through 2007. But growth is expected to slow, becoming “more of a gradual replacement than a major jump,” says analyst Venkat Rajan.

Surprisingly, 40% of surgical gloves sold are still powdered, despite the known hazards of powder.

Market leaders for surgical gloves in order are Cardinal Health, Molnlycke (Biogel), and Ansell.

Cardinal estimates about 18% of its acute care and ambulatory surgery customers have moved entirely to synthetic surgical gloves. Ansell says 6% of the surgical gloves it sells are latex free, up from about 4% 2 years ago.

Newer synthetic materials may be part of the reason some organizations are making the switch to synthetics, says Diane Sosovec, RN, MS, Cardinal’s director, clinical marketing, gloves. Nonlatex polyisoprene gloves are more like latex in flexibility, fit, and comfort than earlier synthetic gloves.

Milt Hinsch, technical services director for Molnlycke’s Biogel glove line, says many customers have looked at the synthetic gloves. But he says almost all decide to use low-protein, powder-free latex gloves for most personnel, reserving nonlatex for patients and staff who are latex sensitized.

Why are synthetics more costly?

The price difference between latex and synthetic surgical gloves ranges widely because there is more of a profit margin on surgical gloves than on exam gloves, notes Christine Miller, RN, portfolio executive for Novation, the purchasing group.

The cost difference per case (200 pairs) for top-of-the-line powder-free surgical latex gloves compared with powder-free nonlatex surgical gloves in most instances is 40% to 70%, says Amy Herrin of Novation.

Both latex and synthetic gloves are challenged by the cost and supply of raw materials. Synthetics, derived from petroleum, are affected by oil prices. The latex market has also seen changes. Latex prices hit a low in 2000, and some Malaysian producers have cut down their rubber trees. Because latex is labor intensive to harvest, less might be produced as Malaysia industrializes, causing prices to rise. (A new type of natural latex that claims to be nonallergenic is entering the scene. See sidebar.)

“With synthetics, we anticipate volume will drive the price down, though this will be complicated by the cost of fuel and value of the dollar,” Miller says.

Though synthetic gloves cost more, Miller says the extra cost must be weighed against the cost of having an employee who is latex sensitized, including risk management, lost work time, workers’ comp, and recruitment for a replacement. Taking these “soft costs” into account, the difference could be a wash, she says.

References

AORN Latex Guideline. 2007 Standards, Recommended Practices, and Guidelines. Denver: AORN, 2007.

Bousquet J, Flahault A, Vendenplas O, et al. Natural rubber latex allergy among health care workers: A systematic review of the evidence. J Allergy Clin Immunol. 2006;118:447-454.

ECRI. Lower-protein latex gloves: A way to reduce allergic reactions in hospital staff. Health Devices. 2004;33:169-174.

Heilman D K, Jones R T, Swanson, M C, et al. A prospective, controlled study showing that rubber gloves are the major contributor to latex aeroallergen levels in the operating room J Allerg Clin Immunol. 1996:98:325-330.

Korniewicz D M, Garzon L, Seltzer J. Failure rates in nonlatex surgical gloves. Am J Infect Control. 2004;32:268-273.

LaMontagne A D, Radi, S, Elder D S, et al. Primary prevention of latex related sensitisation and occupational asthma: A systematic review. Occup Environ Med. 2006;63:359-354.

Smith A M, Amin H S, Biagini R E, et al. Percutaneous reactivity to natural rubber latex proteins persists in health-care workers following avoidance of natural rubber latex. Clin Exp Allergy. 2007;37(9):1349-1356.

New natural latex enters the scene

There’s a new kind of natural latex that could be a safe alternative to the traditional natural latex from rubber trees. It comes from a desert shrub called the guayule (why-you-lee).

Tests show guayule latex is safe for people who have a Type 1 allergy to traditional natural rubber latex, the most severe, says Jeff Martin, CEO of Yulex Corporation, the Phoenix, Arizona-based company that produces guayule latex. He adds that guayule’s protein is different from the protein in traditional latex and much lower so it would be unlikely to sensitize a population.

Medical products made of guayule latex could start coming on the market within 6 to 9 months, and guayule surgical gloves are expected in 18 to 24 months, says Martin.

Unlike tropical latex, which is harvested from the bark of Hevea brasiliensis, the Brazilian rubber tree grown in Southeast Asia, guayule latex is produced by grinding the entire shrub, which releases rubber particles produced in individual cells in its bark.

These tiny rubber balls are washed with purified water and then concentrated to make the latex, Martin explains. He says guayule latex has properties similar to Hevea latex, including the strength, fit, and comfort, yet is inherently low in the safe type of protein.

Tests on guayule’s antigenic properties have been performed by Robert G. Hamilton, PhD, an immunologist from Johns Hopkins, among others. Dr Hamilton tested commercial grade guayule using serum with IgE antibodies from persons allergic to Hevea latex. The results with guayule were the same as those with the synthetic neoprene control, while the Hevea-based latex showed elevated levels of allergen.

Gearing up production

Martin says Yulex is gearing up production of guayule latex, which is grown in the Southwest, and is working with medical device companies to develop prototypes for gloves and other supplies.

The ASTM standard for natural latex (D 1076) has added a new category 4 for natural rubber latex with less than 200 micrograms of total protein per gram and no Hevea antigenic protein. At present, Martin says Yulex latex is the only natural rubber latex that meets this standard.

In the short term, guayule latex products will be more expensive than products made from Hevea latex and will be competitive with synthetics, says Martin. Initially, guayule is expected mainly to be an alternative to synthetics for people sensitized to Hevea latex.

An issue that will need to be resolved is the Food and Drug Administration’s requirement that medical products with natural rubber latex be labeled as such.

This new type of latex will add a wrinkle for those who are making decisions about “latex” versus “latex free.”

Looking for latex-safe resources?

American Latex Allergy Association

Latex allergy information and resources. www.latexallergyresources.org

Premier Inc

Resources provide help in selecting latex-free products:

Publicly accessible resources

Information about latex allergy as well as tools such as sample policies, prevention and control strategies, education, and training tools and advice on products containing latex. www.premierinc.com/safety/

Members-only latex-free catalog

Premier has compiled a 600-page catalog of latex-free products with more than 16,000 items representing 445 suppliers.

Join our community

Learn More
Video Spotlight
Live chat by BoldChat